{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:36:59Z","timestamp":1790638619243,"version":"4.1.0"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00109-025-02613-1","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T11:43:57Z","timestamp":1765626237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stem cells strike back: advancements in Alzheimer\u2019s and Parkinson\u2019s disease treatment and modeling efforts from 2019 to 2024"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-3142","authenticated-orcid":false,"given":"Jasmina","family":"Isakovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Athanassiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Khubeis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"2613_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cca.2020.01.019","volume":"503","author":"C Pe\u00f1a-Bautista","year":"2020","unstructured":"Pe\u00f1a-Bautista C, Casas-Fern\u00e1ndez E, Vento M, Baquero M, Ch\u00e1fer-Peric\u00e1s C (2020) Stress and neurodegeneration. Clin Chim Acta 503:163\u2013168","journal-title":"Clin Chim Acta"},{"key":"2613_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","volume":"14","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA (2010) Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med 14:457\u2013487","journal-title":"J Cell Mol Med"},{"key":"2613_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/nu13092940","author":"D Carregosa","year":"2021","unstructured":"Carregosa D, Mota S, Ferreira S, Alves-Dias B, Loncarevic-Vasiljkovic N, Crespo CL, Menezes R, Teodoro R, Santos CND (2021) Overview of beneficial effects of (poly)phenol metabolites in the context of neurodegenerative diseases on model organisms. Nutrients. https:\/\/doi.org\/10.3390\/nu13092940","journal-title":"Nutrients"},{"key":"2613_CR4","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the parkinson pandemic. J Parkinsons Dis 8:S3\u2013S8","journal-title":"J Parkinsons Dis"},{"key":"2613_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL (2015) Alzheimer\u2019s disease. Nat Rev Dis Primers 1:15056","journal-title":"Nat Rev Dis Primers"},{"key":"2613_CR6","doi-asserted-by":"publisher","first-page":"1361723","DOI":"10.3389\/fmed.2024.1361723","volume":"11","author":"GD Patel","year":"2024","unstructured":"Patel GD, Liu L, Li A, Yang Y-H, Shen C-C, Brand-Saberi B, Yang X (2024) Mesenchymal stem cell-based therapies for treating well-studied neurological disorders: a systematic review. Front Med (Lausanne) 11:1361723","journal-title":"Front Med (Lausanne)"},{"key":"2613_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.31887\/DCNS.2003.5.1\/hhippius","volume":"5","author":"H Hippius","year":"2003","unstructured":"Hippius H, Neund\u00f6rfer G (2003) The discovery of Alzheimer\u2019s disease. Dialogues Clin Neurosci 5:101\u2013108","journal-title":"Dialogues Clin Neurosci"},{"key":"2613_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22042153","author":"F Sivandzade","year":"2021","unstructured":"Sivandzade F, Cucullo L (2021) Regenerative stem cell therapy for neurodegenerative diseases: an overview. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22042153","journal-title":"Int J Mol Sci"},{"key":"2613_CR9","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1007\/s10571-023-01344-6","volume":"43","author":"E Cecerska-Hery\u0107","year":"2023","unstructured":"Cecerska-Hery\u0107 E, P\u0119ka\u0142a M, Serwin N, Gli\u017aniewicz M, Grygorcewicz B, Michalczyk A, Hery\u0107 R, Budkowska M, Do\u0142\u0119gowska B (2023) The use of stem cells as a potential treatment method for selected neurodegenerative diseases: review. Cell Mol Neurobiol 43:2643\u20132673","journal-title":"Cell Mol Neurobiol"},{"key":"2613_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112996","author":"L Bonosi","year":"2022","unstructured":"Bonosi L, Silven MP, Biancardino AA, Sciortino A, Giammalva GR, Scerrati A, Sturiale CL, Albanese A, Tumbiolo S, Visocchi M et al (2022) Stem cell strategies in promoting neuronal regeneration after spinal cord injury: a systematic review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232112996","journal-title":"Int J Mol Sci"},{"key":"2613_CR11","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.4103\/1673-5374.221171","volume":"12","author":"C Wang","year":"2017","unstructured":"Wang C, Lu C-F, Peng J, Hu C-D, Wang Y (2017) Roles of neural stem cells in the repair of peripheral nerve injury. Neural Regen Res 12:2106\u20132112","journal-title":"Neural Regen Res"},{"key":"2613_CR12","doi-asserted-by":"crossref","unstructured":"Bongso A, Lee EH (2005) Stem cells: from bench to bedside. World Scientific Publishing Company, Singapore. ISBN: 978-9812561268","DOI":"10.1142\/9789812569370"},{"key":"2613_CR13","doi-asserted-by":"crossref","unstructured":"Biehl JK, Russell B (2009) Introduction to stem cell therapy. J Cardiovasc Nurs 24:98\u2013103, quiz 104","DOI":"10.1097\/JCN.0b013e318197a6a5"},{"key":"2613_CR14","doi-asserted-by":"publisher","unstructured":"Zhang M, Li K, Xie M, Ding S (2015) Chemical approaches to controlling cell fate. In: Moody SA (ed) Principles of developmental genetics, 2nd edn. Academic Press, pp 59\u201376. ISBN: 9780124059450. https:\/\/doi.org\/10.1016\/B978-0-12-405945-0.00004-1","DOI":"10.1016\/B978-0-12-405945-0.00004-1"},{"key":"2613_CR15","doi-asserted-by":"publisher","unstructured":"Ravichandran VA, Viswanathan P (2021) Biotechnology-based therapeutics. In: Hasija Y (ed) Translational biotechnology. Academic Press, pp 27\u201352. ISBN: 9780128219720. https:\/\/doi.org\/10.1016\/B978-0-12-821972-0.00019-8","DOI":"10.1016\/B978-0-12-821972-0.00019-8"},{"key":"2613_CR16","doi-asserted-by":"publisher","unstructured":"Shah AA, Khan FA (2021) Types and classification of stem cells. In: Khan FA (ed) Advances in application of stem cells: from bench to clinics. Stem Cell Biology and Regenerative Medicine, vol 69. Humana, Cham. ISBN: 978-3-030-78100-2. https:\/\/doi.org\/10.1007\/978-3-030-78101-9_2","DOI":"10.1007\/978-3-030-78101-9_2"},{"key":"2613_CR17","first-page":"17","volume":"3","author":"D Benayahu","year":"2022","unstructured":"Benayahu D (2022) Mesenchymal stem cell differentiation and usage for biotechnology applications: tissue engineering and food manufacturing. Biomater Transl 3:17\u201323","journal-title":"Biomater Transl"},{"key":"2613_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1139359","volume":"11","author":"J Isakovi\u0107","year":"2023","unstructured":"Isakovi\u0107 J, \u0160erer K, Bari\u0161i\u0107 B, Mitre\u010di\u0107 D (2023) Mesenchymal stem cell therapy for neurological disorders: the light or the dark side of the force? Front Bioeng Biotechnol 11:1139359","journal-title":"Front Bioeng Biotechnol"},{"key":"2613_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16020289","author":"T Tashima","year":"2024","unstructured":"Tashima T (2024) Mesenchymal stem cell (MSC)-based drug delivery into the brain across the blood-brain barrier. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics16020289","journal-title":"Pharmaceutics"},{"key":"2613_CR20","doi-asserted-by":"publisher","first-page":"9628536","DOI":"10.1155\/2019\/9628536","volume":"2019","author":"B Lukomska","year":"2019","unstructured":"Lukomska B, Stanaszek L, Zuba-Surma E, Legosz P, Sarzynska S, Drela K (2019) Challenges and controversies in human mesenchymal stem cell therapy. Stem Cells Int 2019:9628536","journal-title":"Stem Cells Int"},{"key":"2613_CR21","first-page":"589","volume":"28","author":"T Vazin","year":"2010","unstructured":"Vazin T, Freed WJ (2010) Human embryonic stem cells: derivation, culture, and differentiation: a review. Restor Neurol Neurosci 28:589\u2013603","journal-title":"Restor Neurol Neurosci"},{"key":"2613_CR22","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/FOC\/2008\/24\/3-4\/E3","volume":"24","author":"S Das","year":"2008","unstructured":"Das S, Bonaguidi M, Muro K, Kessler JA (2008) Generation of embryonic stem cells: limitations of and alternatives to inner cell mass harvest. Neurosurg Focus 24:E4","journal-title":"Neurosurg Focus"},{"key":"2613_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12061350","author":"D-H Lee","year":"2024","unstructured":"Lee D-H, Lee EC, Lee JY, Lee MR, Shim J-W, Oh JS (2024) Neuronal cell differentiation of iPSCs for the clinical treatment of neurological diseases. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12061350","journal-title":"Biomedicines"},{"key":"2613_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2012.09.031","volume":"324","author":"D Karussis","year":"2013","unstructured":"Karussis D, Petrou P, Kassis I (2013) Clinical experience with stem cells and other cell therapies in neurological diseases. J Neurol Sci 324:1\u20139","journal-title":"J Neurol Sci"},{"key":"2613_CR25","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.pmrj.2011.02.011","volume":"3","author":"GJ Ritfeld","year":"2011","unstructured":"Ritfeld GJ, Roos RAC, Oudega M (2011) Stem cells for central nervous system repair and rehabilitation. PM R 3:S117\u2013S122","journal-title":"PM R"},{"key":"2613_CR26","doi-asserted-by":"publisher","first-page":"e13225","DOI":"10.1111\/bpa.13225","volume":"34","author":"Y Cao","year":"2024","unstructured":"Cao Y, Liu P, Bian H, Jin S, Liu J, Yu N, Cui H, Sun F, Qian X, Qiu W et al (2024) Reduced neurogenesis in human hippocampus with Alzheimer\u2019s disease. Brain Pathol 34:e13225","journal-title":"Brain Pathol"},{"key":"2613_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","volume":"367","author":"B Singh","year":"2024","unstructured":"Singh B, Day CM, Abdella S, Garg S (2024) Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management. J Control Release 367:402\u2013424","journal-title":"J Control Release"},{"key":"2613_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.mcna.2020.06.007","volume":"104","author":"L McCollum","year":"2020","unstructured":"McCollum L, Karlawish J (2020) Cognitive impairment evaluation and management. Med Clin North Am 104:807\u2013825","journal-title":"Med Clin North Am"},{"key":"2613_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bmcl.2018.11.034","volume":"29","author":"PV Fish","year":"2019","unstructured":"Fish PV, Steadman D, Bayle ED, Whiting P (2019) New approaches for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem Lett 29:125\u2013133","journal-title":"Bioorg Med Chem Lett"},{"key":"2613_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00043","volume":"13","author":"J Liu","year":"2019","unstructured":"Liu J, Chang L, Song Y, Li H, Wu Y (2019) The role of NMDA receptors in Alzheimer\u2019s disease. Front Neurosci 13:43","journal-title":"Front Neurosci"},{"key":"2613_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/ibra.12098","volume":"9","author":"B-C Tang","year":"2023","unstructured":"Tang B-C, Wang Y-T, Ren J (2023) Basic information about memantine and its treatment of Alzheimer\u2019s disease and other clinical applications. Ibrain 9:340\u2013348","journal-title":"Ibrain"},{"key":"2613_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyu115","author":"S Matsunaga","year":"2014","unstructured":"Matsunaga S, Kishi T, Iwata N (2014) Combination therapy with cholinesterase inhibitors and memantine for Alzheimer\u2019s disease: a systematic review and meta-analysis. Int J Neuropsychopharmacol. https:\/\/doi.org\/10.1093\/ijnp\/pyu115","journal-title":"Int J Neuropsychopharmacol"},{"key":"2613_CR33","first-page":"31925","volume":"10","author":"HW Haddad","year":"2022","unstructured":"Haddad HW, Malone GW, Comardelle NJ, Degueure AE, Kaye AM, Kaye AD (2022) Aducanumab, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer\u2019s disease: a comprehensive review. Health Psychol Res 10:31925","journal-title":"Health Psychol Res"},{"key":"2613_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/03946320231209839","volume":"37","author":"S Chowdhury","year":"2023","unstructured":"Chowdhury S, Chowdhury NS (2023) Novel anti-amyloid-beta (A\u03b2) monoclonal antibody lecanemab for Alzheimer\u2019s disease: a systematic review. Int J Immunopathol Pharmacol 37:3946320231209839","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2613_CR35","first-page":"264","volume":"39","author":"T Bennett","year":"2014","unstructured":"Bennett T, Bray D, Neville MW (2014) Suvorexant, a dual orexin receptor antagonist for the management of insomnia. PT 39:264\u2013266","journal-title":"PT"},{"key":"2613_CR36","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jamaneurol.2023.3810","volume":"80","author":"D Lee","year":"2023","unstructured":"Lee D, Slomkowski M, Hefting N, Chen D, Larsen KG, Kohegyi E, Hobart M, Cummings JL, Grossberg GT (2023) Brexpiprazole for the treatment of agitation in alzheimer dementia: a randomized clinical trial. JAMA Neurol 80:1307\u20131316","journal-title":"JAMA Neurol"},{"key":"2613_CR37","doi-asserted-by":"publisher","first-page":"1222197","DOI":"10.3389\/fnagi.2023.1222197","volume":"15","author":"AM Gonz\u00e1lez-Mart\u00edn","year":"2023","unstructured":"Gonz\u00e1lez-Mart\u00edn AM, Aibar Almaz\u00e1n A, Rivas Campo Y, Rodr\u00edguez Sobrino N, Castellote Caballero Y (2023) Addressing depression in older adults with Alzheimer\u2019s through cognitive behavioral therapy: systematic review and meta-analysis. Front Aging Neurosci 15:1222197","journal-title":"Front Aging Neurosci"},{"key":"2613_CR38","doi-asserted-by":"publisher","first-page":"e026308","DOI":"10.1136\/bmjopen-2018-026308","volume":"9","author":"S Bennett","year":"2019","unstructured":"Bennett S, Laver K, Voigt-Radloff S, Letts L, Clemson L, Graff M, Wiseman J, Gitlin L (2019) Occupational therapy for people with dementia and their family carers provided at home: a systematic review and meta-analysis. BMJ Open 9:e026308","journal-title":"BMJ Open"},{"key":"2613_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1243869","volume":"15","author":"HA Pahlavani","year":"2023","unstructured":"Pahlavani HA (2023) Exercise therapy to prevent and treat Alzheimer\u2019s disease. Front Aging Neurosci 15:1243869","journal-title":"Front Aging Neurosci"},{"key":"2613_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00132","volume":"13","author":"M Leggieri","year":"2019","unstructured":"Leggieri M, Thaut MH, Fornazzari L, Schweizer TA, Barfett J, Munoz DG, Fischer CE (2019) Music intervention approaches for Alzheimer\u2019s disease: a review of the literature. Front Neurosci 13:132","journal-title":"Front Neurosci"},{"key":"2613_CR41","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3233\/JAD-2012-121645","volume":"33","author":"N Hanford","year":"2013","unstructured":"Hanford N, Figueiro M (2013) Light therapy and Alzheimer\u2019s disease and related dementia: past, present, and future. J Alzheimers Dis 33:913\u2013922","journal-title":"J Alzheimers Dis"},{"key":"2613_CR42","doi-asserted-by":"publisher","first-page":"108615","DOI":"10.1016\/j.celrep.2020.108615","volume":"34","author":"C Arber","year":"2021","unstructured":"Arber C, Lovejoy C, Harris L, Willumsen N, Alatza A, Casey JM, Lines G, Kerins C, Mueller AK, Zetterberg H et al (2021) Familial Alzheimer\u2019s disease mutations in PSEN1 lead to premature human stem cell neurogenesis. Cell Rep 34:108615","journal-title":"Cell Rep"},{"key":"2613_CR43","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.stemcr.2023.05.018","volume":"18","author":"EM Hurley","year":"2023","unstructured":"Hurley EM, Mozolewski P, Dobrowolski R, Hsieh J (2023) Familial Alzheimer\u2019s disease-associated PSEN1 mutations affect neurodevelopment through increased Notch signaling. Stem Cell Reports 18:1516\u20131533","journal-title":"Stem Cell Reports"},{"key":"2613_CR44","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s12015-021-10254-3","volume":"18","author":"M Barak","year":"2022","unstructured":"Barak M, Fedorova V, Pospisilova V, Raska J, Vochyanova S, Sedmik J, Hribkova H, Klimova H, Vanova T, Bohaciakova D (2022) Human iPSC-derived neural models for studying Alzheimer\u2019s disease: from neural stem cells to cerebral organoids. Stem Cell Rev Rep 18:792\u2013820","journal-title":"Stem Cell Rev Rep"},{"key":"2613_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mcn.2015.11.010","volume":"73","author":"AE Mungenast","year":"2016","unstructured":"Mungenast AE, Siegert S, Tsai L-H (2016) Modeling Alzheimer\u2019s disease with human induced pluripotent stem (iPS) cells. Mol Cell Neurosci 73:13\u201331","journal-title":"Mol Cell Neurosci"},{"key":"2613_CR46","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1017\/S0033291717002124","volume":"47","author":"JP Robbins","year":"2017","unstructured":"Robbins JP, Price J (2017) Human induced pluripotent stem cells as a research tool in Alzheimer\u2019s disease. Psychol Med 47:2587\u20132592","journal-title":"Psychol Med"},{"key":"2613_CR47","doi-asserted-by":"publisher","first-page":"166712","DOI":"10.1016\/j.bbadis.2023.166712","volume":"1869","author":"JS Bhatti","year":"2023","unstructured":"Bhatti JS, Khullar N, Mishra J, Kaur S, Sehrawat A, Sharma E, Bhatti GK, Selman A, Reddy PH (2023) Stem cells in the treatment of Alzheimer\u2019s disease - promises and pitfalls. Biochimica et Biophysica Acta (BBA) 1869:166712","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"2613_CR48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13287-022-02765-8","volume":"13","author":"C Qin","year":"2022","unstructured":"Qin C, Bai L, Li Y, Wang K (2022) The functional mechanism of bone marrow-derived mesenchymal stem cells in the treatment of animal models with Alzheimer\u2019s disease: crosstalk between autophagy and apoptosis. Stem Cell Res Ther 13:90","journal-title":"Stem Cell Res Ther"},{"key":"2613_CR49","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1177\/0004867420917467","volume":"54","author":"B-N Park","year":"2020","unstructured":"Park B-N, Kim J-H, Lim TS, Park SH, Kim T-G, Yoon BS, Son KS, Yoon J-K, An Y-S (2020) Therapeutic effect of mesenchymal stem cells in an animal model of Alzheimer\u2019s disease evaluated by \u03b2-amyloid positron emission tomography imaging. Aust N Z J Psychiatry 54:883\u2013891","journal-title":"Aust N Z J Psychiatry"},{"key":"2613_CR50","doi-asserted-by":"publisher","first-page":"e00977","DOI":"10.1002\/prp2.977","volume":"10","author":"A Madani Neishaboori","year":"2022","unstructured":"Madani Neishaboori A, Eshraghi A, Tasouji Asl A, Shariatpanahi M, Yousefifard M, Gorji A (2022) Adipose tissue-derived stem cells as a potential candidate in treatment of Alzheimer\u2019s disease: a systematic review on preclinical studies. Pharmacol Res Perspect 10:e00977","journal-title":"Pharmacol Res Perspect"},{"key":"2613_CR51","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s11011-019-00421-4","volume":"34","author":"E Nasiri","year":"2019","unstructured":"Nasiri E, Alizadeh A, Roushandeh AM, Gazor R, Hashemi-Firouzi N, Golipoor Z (2019) Melatonin-pretreated adipose-derived mesenchymal stem cells efficeintly improved learning, memory, and cognition in an animal model of Alzheimer\u2019s disease. Metab Brain Dis 34:1131\u20131143","journal-title":"Metab Brain Dis"},{"key":"2613_CR52","doi-asserted-by":"publisher","first-page":"113224","DOI":"10.1016\/j.biopha.2022.113224","volume":"152","author":"M Sheykhhasan","year":"2022","unstructured":"Sheykhhasan M, Amini R, Soleimani Asl S, Saidijam M, Hashemi SM, Najafi R (2022) Neuroprotective effects of coenzyme Q10-loaded exosomes obtained from adipose-derived stem cells in a rat model of Alzheimer\u2019s disease. Biomed Pharmacother 152:113224","journal-title":"Biomed Pharmacother"},{"key":"2613_CR53","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1021\/acs.nanolett.2c03682","volume":"23","author":"M Jung","year":"2023","unstructured":"Jung M, Kim H, Hwang JW, Choi Y, Kang M, Kim C, Hong J, Lee NK, Moon S, Chang JW et al (2023) Iron oxide nanoparticle-incorporated mesenchymal stem cells for Alzheimer\u2019s disease treatment. Nano Lett 23:476\u2013490","journal-title":"Nano Lett"},{"key":"2613_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2021.102507","volume":"40","author":"Y Wang","year":"2022","unstructured":"Wang Y, Jiang J, Fu X, Zhang J, Song J, Wang Y, Duan L, Shao P, Xu X, Zeng L et al (2022) Fe3O4@polydopamine nanoparticle-loaded human umbilical cord mesenchymal stem cells improve the cognitive function in Alzheimer\u2019s disease mice by promoting hippocampal neurogenesis. Nanomedicine 40:102507","journal-title":"Nanomedicine"},{"key":"2613_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13195-021-00791-x","volume":"13","author":"LA Apodaca","year":"2021","unstructured":"Apodaca LA, Baddour AAD, Garcia C, Alikhani L, Giedzinski E, Ru N, Agrawal A, Acharya MM, Baulch JE (2021) Human neural stem cell-derived extracellular vesicles mitigate hallmarks of Alzheimer\u2019s disease. Alzheimers Res Ther 13:57","journal-title":"Alzheimers Res Ther"},{"key":"2613_CR56","unstructured":"Bernamel B (2025) A Phase I, prospective, open\u2011label trial to evaluate the safety, tolerability and exploratory outcomes of multiple allogeneic human mesenchymal stem cells (hMSC) infusions in patients with mild to moderate Alzheimer\u2019s disease (ClinicalTrials.gov Identifier NCT04040348). ClinicalTrials.gov. University of Miami.\u00a0https:\/\/clinicaltrials.gov\/study\/NCT04040348.\u00a0Accessed 12 Aug 2024"},{"key":"2613_CR57","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13195-021-00897-2","volume":"13","author":"HJ Kim","year":"2021","unstructured":"Kim HJ, Cho KR, Jang H, Lee NK, Jung YH, Kim JP, Lee JI, Chang JW, Park S, Kim ST et al (2021) Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: a phase I clinical trial. Alzheimers Res Ther 13:154","journal-title":"Alzheimers Res Ther"},{"key":"2613_CR58","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/alz.12651","volume":"19","author":"M Brody","year":"2023","unstructured":"Brody M, Agronin M, Herskowitz BJ, Bookheimer SY, Small GW, Hitchinson B, Ramdas K, Wishard T, McInerney KF, Vellas B et al (2023) Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer\u2019s disease. Alzheimers Dement 19:261\u2013273","journal-title":"Alzheimers Dement"},{"key":"2613_CR59","unstructured":"Hope Biosciences Stem Cell Research Foundation (2021) A clinical trial to determine the safety and efficacy of hope biosciences autologous mesenchymal stem cell therapy (HB-adMSCs) for the treatment of Alzheimer\u2019s disease (ClinicalTrials.gov) Available at: https:\/\/clinicaltrials.gov\/study\/NCT04228666?cond=NCT04228666&rank=1 .Accessed 12 Aug. 2024."},{"key":"2613_CR60","unstructured":"Regeneration Biomedical, Inc (2024) Autologous activated adipose-derived stem cells (RB-ADSC) injected directly into the brain for mild to moderate Alzheimer\u2019s disease (ClinicalTrials.gov) Available at: https:\/\/clinicaltrials.gov\/study\/NCT05667649?cond=NCT05667649&rank=1. Accessed 12 Aug 2024"},{"key":"2613_CR61","unstructured":"Thomas Advanced Medical LLC (2022) Mesenchymal stem cells for the treatment of various chronic and acute conditions (ClinicalTrials.gov) available at: https:\/\/clinicaltrials.gov\/study\/NCT04684602?cond=NCT04684602&rank=1. Accessed 12 August 2024"},{"key":"2613_CR62","unstructured":"Nature Cell Co. Ltd (2022) Study to evaluate the safety and efficacy of AstroStem in treatment of Alzheimer\u2019s disease (ClinicalTrials.gov) available at: https:\/\/clinicaltrials.gov\/study\/NCT04482413?cond=NCT04482413&rank=1. Accessed 12 Aug 2024"},{"key":"2613_CR63","unstructured":"R3 Stem Cell (2019). Safety and Clinical outcomes with amniotic and umbilical cord tissue therapy for numerous medical conditions (ClinicalTrials.gov) available at: https:\/\/clinicaltrials.gov\/study\/NCT03899298?cond=NCT03899298&rank=1 .Accessed August 12, 2024"},{"key":"2613_CR64","unstructured":"Na DL (2021) Exploratory efficacy study of NEUROSTEM\u00ae in subjects who control group of NEUROSTEM\u00ae (ClinicalTrials.gov) Available at: https:\/\/clinicaltrials.gov\/study\/NCT04954534?cond=NCT04954534&rank=1. Accessed 12 Aug 2024"},{"key":"2613_CR65","unstructured":"Ruijin Hospital (2021) The safety and the efficacy evaluation of allogenic adipose MSC-exos in patients with Alzheimer\u2019s disease (ClinicalTrials.gov) available at: https:\/\/clinicaltrials.gov\/study\/NCT04388982?cond=NCT04388982&rank=1 Accessed August 12, 2024."},{"key":"2613_CR66","unstructured":"Welter R (2018) Autologous stem\/stromal cells in neurological disorders and disease (NDD) (ClinicalTrials.gov) Available at: https:\/\/clinicaltrials.gov\/study\/NCT03297177?cond=NCT03297177&rank=1. Accessed 12 Aug 2024"},{"key":"2613_CR67","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3233\/JPD-225060","volume":"13","author":"W Pirker","year":"2023","unstructured":"Pirker W, Katzenschlager R, Hallett M, Poewe W (2023) Pharmacological treatment of tremor in Parkinson\u2019s disease revisited. J Parkinsons Dis 13:127\u2013144","journal-title":"J Parkinsons Dis"},{"key":"2613_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137183","author":"M Muleiro Alvarez","year":"2024","unstructured":"Muleiro Alvarez M, Cano-Herrera G, Osorio Mart\u00ednez MF, Vega Gonzales-Portillo J, Monroy GR, Murguiondo P\u00e9rez R, Torres-R\u00edos JA, van Tienhoven XA, Garibaldi Bernot EM, Esparza Salazar F et al (2024) A comprehensive approach to Parkinson\u2019s disease: addressing its molecular, clinical, and therapeutic aspects. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25137183","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"2613_CR69","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1016\/j.parkreldis.2015.09.028","volume":"22","author":"M Beudel","year":"2016","unstructured":"Beudel M, Brown P (2016) Adaptive deep brain stimulation in Parkinson\u2019s disease. Parkinsonism Relat Disord 22(Suppl 1):S123\u2013S126","journal-title":"Parkinsonism Relat Disord"},{"key":"2613_CR70","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.wneu.2023.08.069","volume":"179","author":"AR Tewari","year":"2023","unstructured":"Tewari AR, Grogan DP, Maragkos GA, Elias WJ, Moosa S (2023) A new era for lesioning in parkinson disease. World Neurosurg 179:236\u2013237","journal-title":"World Neurosurg"},{"key":"2613_CR71","doi-asserted-by":"publisher","first-page":"e0307304","DOI":"10.1371\/journal.pone.0307304","volume":"19","author":"P Bosch-Barcel\u00f3","year":"2024","unstructured":"Bosch-Barcel\u00f3 P, Climent-Sanz C, Mart\u00ednez-Navarro O, Masbernat-Almenara M, Pakarinen A, Ghosh PK, Fern\u00e1ndez-Lago H (2024) A treadmill training program in a gamified virtual reality environment combined with transcranial direct current stimulation in Parkinson\u2019s disease: study protocol for a randomized controlled trial. PLoS ONE 19:e0307304","journal-title":"PLoS ONE"},{"key":"2613_CR72","doi-asserted-by":"publisher","unstructured":"Herd CP, Tomlinson CL, Deane KHO, Brady MC, Smith CH, Sackley CM, Clarke CE (2012) Speech and language therapy versus placebo or no intervention for speech problems in Parkinson\u2019s disease. Cochrane Database Syst Rev 8:CD002812. John Wiley & Sons, Ltd.\u00a0https:\/\/doi.org\/10.1002\/14651858.CD002812","DOI":"10.1002\/14651858.CD002812"},{"key":"2613_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1354864","volume":"18","author":"Y Yang","year":"2024","unstructured":"Yang Y, Yan Z, Chang W, Ding J, Xu H (2024) Effect of different modalities of transcranial magnetic stimulation on Parkinson\u2019s patients cognitive impairment and long-term effectiveness: a systematic review and network meta-analysis. Front Neurosci 18:1354864","journal-title":"Front Neurosci"},{"key":"2613_CR74","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/bpa.12526","volume":"27","author":"K Singh Dolt","year":"2017","unstructured":"Singh Dolt K, Hammachi F, Kunath T (2017) Modeling Parkinson\u2019s disease with induced pluripotent stem cells harboring \u03b1-synuclein mutations. Brain Pathol 27:545\u2013551","journal-title":"Brain Pathol"},{"key":"2613_CR75","doi-asserted-by":"publisher","first-page":"349","DOI":"10.5483\/BMBRep.2019.52.6.142","volume":"52","author":"Y Oh","year":"2019","unstructured":"Oh Y (2019) Patient-specific pluripotent stem cell-based Parkinson\u2019s disease models showing endogenous alpha-synuclein aggregation. BMB Rep 52:349\u2013359","journal-title":"BMB Rep"},{"key":"2613_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/genes13111937","author":"J Kim","year":"2022","unstructured":"Kim J, Daadi EW, Oh T, Daadi ES, Daadi MM (2022) Human induced pluripotent stem cell phenotyping and preclinical modeling of familial parkinson\u2019s disease. Genes. https:\/\/doi.org\/10.3390\/genes13111937","journal-title":"Genes"},{"key":"2613_CR77","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1093\/hmg\/ddv212","volume":"24","author":"E Ohta","year":"2015","unstructured":"Ohta E, Nihira T, Uchino A, Imaizumi Y, Okada Y, Akamatsu W, Takahashi K, Hayakawa H, Nagai M, Ohyama M et al (2015) I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT\/GSK-3\u03b2 signaling pathway. Hum Mol Genet 24:4879\u20134900","journal-title":"Hum Mol Genet"},{"key":"2613_CR78","doi-asserted-by":"publisher","first-page":"141ra90","DOI":"10.1126\/scitranslmed.3003985","volume":"4","author":"O Cooper","year":"2012","unstructured":"Cooper O, Seo H, Andrabi S, Guardia-Laguarta C, Graziotto J, Sundberg M, McLean JR, Carrillo-Reid L, Xie Z, Osborn T et al (2012) Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson\u2019s disease. Sci Transl Med 4:141ra90","journal-title":"Sci Transl Med"},{"key":"2613_CR79","doi-asserted-by":"publisher","first-page":"E3679","DOI":"10.1073\/pnas.1617259114","volume":"114","author":"G Kouroupi","year":"2017","unstructured":"Kouroupi G, Taoufik E, Vlachos IS, Tsioras K, Antoniou N, Papastefanaki F, Chroni-Tzartou D, Wrasidlo W, Bohl D, Stellas D et al (2017) Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson\u2019s disease. Proc Natl Acad Sci U S A 114:E3679\u2013E3688","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2613_CR80","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1134\/S0006297923040077","volume":"88","author":"VB Fedoseyeva","year":"2023","unstructured":"Fedoseyeva VB, Novosadova EV, Nenasheva VV, Novosadova LV, Grivennikov IA, Tarantul VZ (2023) Activation of embryonic gene transcription in neural precursor cells derived from the induced pluripotent stem cells of the patients with Parkinson\u2019s disease. Biochemistry (Mosc) 88:515\u2013525","journal-title":"Biochemistry (Mosc)"},{"key":"2613_CR81","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1756-6606-5-35","volume":"5","author":"Y Imaizumi","year":"2012","unstructured":"Imaizumi Y, Okada Y, Akamatsu W, Koike M, Kuzumaki N, Hayakawa H, Nihira T, Kobayashi T, Ohyama M, Sato S et al (2012) Mitochondrial dysfunction associated with increased oxidative stress and \u03b1-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol Brain 5:35","journal-title":"Mol Brain"},{"key":"2613_CR82","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1016\/j.stemcr.2021.09.014","volume":"16","author":"T Oosterveen","year":"2021","unstructured":"Oosterveen T, Gar\u00e7\u00e3o P, Moles-Garcia E, Soleilhavoup C, Travaglio M, Sheraz S, Peltrini R, Patrick K, Labas V, Combes-Soia L et al (2021) Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson\u2019s disease. Stem Cell Reports 16:2718\u20132735","journal-title":"Stem Cell Reports"},{"key":"2613_CR83","doi-asserted-by":"publisher","first-page":"108741","DOI":"10.1016\/j.jneumeth.2020.108741","volume":"340","author":"E Ferrari","year":"2020","unstructured":"Ferrari E, Cardinale A, Picconi B, Gardoni F (2020) From cell lines to pluripotent stem cells for modelling Parkinson\u2019s disease. J Neurosci Methods 340:108741","journal-title":"J Neurosci Methods"},{"key":"2613_CR84","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11910-018-0893-8","volume":"18","author":"SL Sison","year":"2018","unstructured":"Sison SL, Vermilyea SC, Emborg ME, Ebert AD (2018) Using patient-derived induced pluripotent stem cells to identify Parkinson\u2019s disease-relevant phenotypes. Curr Neurol Neurosci Rep 18:84","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2613_CR85","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neures.2023.06.001","volume":"195","author":"N Patikas","year":"2023","unstructured":"Patikas N, Ansari R, Metzakopian E (2023) Single-cell transcriptomics identifies perturbed molecular pathways in midbrain organoids using \u03b1-synuclein triplication Parkinson\u2019s disease patient-derived iPSCs. Neurosci Res 195:13\u201328","journal-title":"Neurosci Res"},{"key":"2613_CR86","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2021.07.017","volume":"107","author":"J Burtscher","year":"2021","unstructured":"Burtscher J, Syed MMK, Keller MA, Lashuel HA, Millet GP (2021) Fatal attraction - the role of hypoxia when alpha-synuclein gets intimate with mitochondria. Neurobiol Aging 107:128\u2013141","journal-title":"Neurobiol Aging"},{"key":"2613_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/cells12242860","author":"LF Cardo","year":"2023","unstructured":"Cardo LF, Monz\u00f3n-Sandoval J, Li Z, Webber C, Li M (2023) Single-cell transcriptomics and in vitro lineage tracing reveals differential susceptibility of human iPSC-derived midbrain dopaminergic neurons in a cellular model of Parkinson\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/cells12242860","journal-title":"Cells"},{"key":"2613_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/cells12212565","author":"B Mendes-Pinheiro","year":"2023","unstructured":"Mendes-Pinheiro B, Campos J, Marote A, Soares-Cunha C, Nickels SL, Monzel AS, Cibr\u00e3o JR, Loureiro-Campos E, Serra SC, Barata-Antunes S et al (2023) Treating Parkinson\u2019s disease with human bone marrow mesenchymal stem cell secretome: a translational investigation using human brain organoids and different routes of in vivo administration. Cells. https:\/\/doi.org\/10.3390\/cells12212565","journal-title":"Cells"},{"key":"2613_CR89","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.7150\/thno.80271","volume":"13","author":"X Zheng","year":"2023","unstructured":"Zheng X, Han D, Liu W, Wang X, Pan N, Wang Y, Chen Z (2023) Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson\u2019s disease. Theranostics 13:2673\u20132692","journal-title":"Theranostics"},{"key":"2613_CR90","doi-asserted-by":"publisher","first-page":"105324","DOI":"10.1016\/j.neuint.2022.105324","volume":"155","author":"Y Guo","year":"2022","unstructured":"Guo Y, Guan Y, Zhu H, Sun T, Wang Y, Huang Y, Ma C, Emery R, Guan W, Wang C et al (2022) Therapeutic function of iPSCs-derived primitive neuroepithelial cells in a rat model of Parkinson\u2019s disease. Neurochem Int 155:105324","journal-title":"Neurochem Int"},{"key":"2613_CR91","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1038\/s41467-020-17165-w","volume":"11","author":"D Doi","year":"2020","unstructured":"Doi D, Magotani H, Kikuchi T, Ikeda M, Hiramatsu S, Yoshida K, Amano N, Nomura M, Umekage M, Morizane A et al (2020) Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson\u2019s disease. Nat Commun 11:3369","journal-title":"Nat Commun"},{"key":"2613_CR92","doi-asserted-by":"publisher","first-page":"e14630","DOI":"10.1111\/cns.14630","volume":"30","author":"H Liang","year":"2024","unstructured":"Liang H, Liu P, Wang Z, Xiong H, Yin C, Zhao D, Wu C, Chen L (2024) TREM2 gene induces differentiation of induced pluripotent stem cells into dopaminergic neurons and promotes neuronal repair via TGF-\u03b2 activation in 6-OHDA-lesioned mouse model of Parkinson\u2019s disease. CNS Neurosci Ther 30:e14630","journal-title":"CNS Neurosci Ther"},{"key":"2613_CR93","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00441-022-03736-4","volume":"391","author":"Y Guo","year":"2023","unstructured":"Guo Y, Zhu H, Wang Y, Sun T, Xu J, Wang T, Guan W, Wang C, Liu C, Ma C (2023) Miniature-swine iPSC-derived GABA progenitor cells function in a rat Parkinson\u2019s disease model. Cell Tissue Res 391:425\u2013440","journal-title":"Cell Tissue Res"},{"key":"2613_CR94","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks S, Shim J-W, Piao J, Ganat YM, Wakeman DR, Xie Z, Carrillo-Reid L, Auyeung G, Antonacci C, Buch A et al (2011) Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease. Nature 480:547\u2013551","journal-title":"Nature"},{"key":"2613_CR95","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.stem.2020.08.014","volume":"28","author":"M Xiong","year":"2021","unstructured":"Xiong M, Tao Y, Gao Q, Feng B, Yan W, Zhou Y, Kotsonis TA, Yuan T, You Z, Wu Z et al (2021) Human stem cell-derived neurons repair circuits and restore neural function. Cell Stem Cell 28:112-126.e6","journal-title":"Cell Stem Cell"},{"key":"2613_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111359","author":"G Edwards III","year":"2019","unstructured":"Edwards G Iii, Gamez N, Armijo E, Kramm C, Morales R, Taylor-Presse K, Schulz PE, Soto C, Moreno-Gonzalez I (2019) Peripheral delivery of neural precursor cells ameliorates Parkinson\u2019s disease-associated pathology. Cells. https:\/\/doi.org\/10.3390\/cells8111359","journal-title":"Cells"},{"key":"2613_CR97","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41419-020-2473-5","volume":"11","author":"H-X Chen","year":"2020","unstructured":"Chen H-X, Liang F-C, Gu P, Xu B-L, Xu H-J, Wang W-T, Hou J-Y, Xie D-X, Chai X-Q, An S-J (2020) Exosomes derived from mesenchymal stem cells repair a Parkinson\u2019s disease model by inducing autophagy. Cell Death Dis 11:288","journal-title":"Cell Death Dis"},{"key":"2613_CR98","doi-asserted-by":"publisher","first-page":"151927","DOI":"10.1016\/j.acthis.2022.151927","volume":"124","author":"F Li","year":"2022","unstructured":"Li F, Zhang A, Li M, Wang X, Wang X, Guan Y, An J, Han D, Zhang YA, Chen Z (2022) Induced neural stem cells from Macaca fascicularis show potential of dopaminergic neuron specification and efficacy in a mouse Parkinson\u2019s disease model. Acta Histochem 124:151927","journal-title":"Acta Histochem"},{"key":"2613_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020654","author":"KY Kim","year":"2021","unstructured":"Kim KY, Chang K-A (2021) Therapeutic potential of magnetic nanoparticle-based human adipose-derived stem cells in a mouse model of Parkinson\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22020654","journal-title":"Int J Mol Sci"},{"key":"2613_CR100","doi-asserted-by":"publisher","first-page":"963689720908512","DOI":"10.1177\/0963689720908512","volume":"29","author":"S Sun","year":"2020","unstructured":"Sun S, Zhang Q, Li M, Gao P, Huang K, Beejadhursing R, Jiang W, Lei T, Zhu M, Shu K (2020) GDNF promotes survival and therapeutic efficacy of human adipose-derived mesenchymal stem cells in a mouse model of Parkinson\u2019s disease. Cell Transplant 29:963689720908512","journal-title":"Cell Transplant"},{"key":"2613_CR101","doi-asserted-by":"publisher","DOI":"10.1177\/09636897221149130","volume":"32","author":"M Li","year":"2023","unstructured":"Li M, Li J, Chen H, Zhu M (2023) VEGF-expressing mesenchymal stem cell therapy for safe and effective treatment of pain in Parkinson\u2019s disease. Cell Transplant 32:9636897221149130","journal-title":"Cell Transplant"},{"key":"2613_CR102","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.21873\/invivo.13300","volume":"37","author":"L Chan","year":"2023","unstructured":"Chan L, Hsu W, Chen K-Y, Wang W, Hung Y-C, Hong C-T (2023) Therapeutic effect of human adipocyte-derived stem cell-derived exosomes on a transgenic mouse model of Parkinson\u2019s disease. In Vivo 37:2028\u20132038","journal-title":"In Vivo"},{"key":"2613_CR103","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40035-023-00368-8","volume":"12","author":"A Dovonou","year":"2023","unstructured":"Dovonou A, Bolduc C, Soto Linan V, Gora C, Peralta Iii MR, L\u00e9vesque M (2023) Animal models of Parkinson\u2019s disease: bridging the gap between disease hallmarks and research questions. Transl Neurodegener 12:36","journal-title":"Transl Neurodegener"},{"key":"2613_CR104","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s12640-020-00290-1","volume":"39","author":"S Simorgh","year":"2021","unstructured":"Simorgh S, Alizadeh R, Shabani R, Karimzadeh F, Seidkhani E, Majidpoor J, Moradi F, Kasbiyan H (2021) Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease. Neurotox Res 39:598\u2013608","journal-title":"Neurotox Res"},{"key":"2613_CR105","doi-asserted-by":"publisher","first-page":"9420","DOI":"10.1016\/j.biomaterials.2013.08.073","volume":"34","author":"DB Hoban","year":"2013","unstructured":"Hoban DB, Newland B, Moloney TC, Howard L, Pandit A, Dowd E (2013) The reduction in immunogenicity of neurotrophin overexpressing stem cells after intra-striatal transplantation by encapsulation in an in situ gelling collagen hydrogel. Biomaterials 34:9420\u20139429","journal-title":"Biomaterials"},{"key":"2613_CR106","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/term.3081","volume":"14","author":"A Santaella","year":"2020","unstructured":"Santaella A, Wessels HJCT, Kulkarni P, Gloerich J, Kuiperij B, Bloem BR, van Gool AJ, Cabr\u00e9 S, Alamilla V, Verbeek MM (2020) Proteomic profiling of striatal tissue of a rat model of Parkinson\u2019s disease after implantation of collagen-encapsulated human umbilical cord mesenchymal stem cells. J Tissue Eng Regen Med 14:1077\u20131086","journal-title":"J Tissue Eng Regen Med"},{"key":"2613_CR107","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/jcp.24909","volume":"230","author":"HES Marei","year":"2015","unstructured":"Marei HES, Lashen S, Farag A, Althani A, Afifi N, A A-E, Rezk S, Pallini R, Casalbore P, Cenciarelli C (2015) Human olfactory bulb neural stem cells mitigate movement disorders in a rat model of Parkinson\u2019s disease. J Cell Physiol 230:1614\u20131629","journal-title":"J Cell Physiol"},{"key":"2613_CR108","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/ejn.13504","volume":"45","author":"R Alizadeh","year":"2017","unstructured":"Alizadeh R, Hassanzadeh G, Joghataei MT, Soleimani M, Moradi F, Mohammadpour S, Ghorbani J, Safavi A, Sarbishegi M, Pirhajati Mahabadi V et al (2017) In vitro differentiation of neural stem cells derived from human olfactory bulb into dopaminergic-like neurons. Eur J Neurosci 45:773\u2013784","journal-title":"Eur J Neurosci"},{"key":"2613_CR109","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1007\/s12035-016-0027-8","volume":"54","author":"Y-H Li","year":"2017","unstructured":"Li Y-H, Yu J-W, Xi J-Y, Yu W-B, Liu J-C, Wang Q, Song L-J, Feng L, Yan Y-P, Zhang G-X et al (2017) Fasudil enhances therapeutic efficacy of neural stem cells in the mouse model of MPTP-induced Parkinson\u2019s Disease. Mol Neurobiol 54:5400\u20135413","journal-title":"Mol Neurobiol"},{"key":"2613_CR110","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ebiom.2016.04.016","volume":"8","author":"W Altarche-Xifro","year":"2016","unstructured":"Altarche-Xifro W, di Vicino U, Mu\u00f1oz-Martin MI, Bortolozzi A, Bov\u00e9 J, Vila M, Cosma MP (2016) Functional rescue of dopaminergic neuron loss in Parkinson\u2019s disease mice after transplantation of hematopoietic stem and progenitor cells. EBioMedicine 8:83\u201395","journal-title":"EBioMedicine"},{"key":"2613_CR111","doi-asserted-by":"publisher","first-page":"693438","DOI":"10.3389\/fmedt.2022.693438","volume":"4","author":"AR Mutepfa","year":"2022","unstructured":"Mutepfa AR, Hardy JG, Adams CF (2022) Electroactive scaffolds to improve neural stem cell therapy for spinal cord injury. Front Med Technol 4:693438","journal-title":"Front Med Technol"},{"key":"2613_CR112","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.7150\/thno.26643","volume":"8","author":"Y Yuan","year":"2018","unstructured":"Yuan Y, Tang X, Bai Y-F, Wang S, An J, Wu Y, Xu Z-QD, Zhang YA, Chen Z (2018) Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson\u2019s disease model. Theranostics 8:4679\u20134694","journal-title":"Theranostics"},{"key":"2613_CR113","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1186\/s12967-023-04638-x","volume":"21","author":"S He","year":"2023","unstructured":"He S, Wang Q, Chen L, He YJ, Wang X, Qu S (2023) MiR-100a-5p-enriched exosomes derived from mesenchymal stem cells enhance the anti-oxidant effect in a Parkinson\u2019s disease model via regulation of Nox4\/ROS\/Nrf2 signaling. J Transl Med 21:747","journal-title":"J Transl Med"},{"key":"2613_CR114","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1016\/j.ymthe.2022.06.003","volume":"30","author":"M Esteves","year":"2022","unstructured":"Esteves M, Abreu R, Fernandes H, Serra-Almeida C, Martins PAT, Bar\u00e3o M, Crist\u00f3v\u00e3o AC, Saraiva C, Ferreira R, Ferreira L et al (2022) MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson\u2019s disease. Mol Ther 30:3176\u20133192","journal-title":"Mol Ther"},{"key":"2613_CR115","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","volume":"9","author":"R Kojima","year":"2018","unstructured":"Kojima R, Bojar D, Rizzi G, Hamri GC-E, El-Baba MD, Saxena P, Ausl\u00e4nder S, Tan KR, Fussenegger M (2018) Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment. Nat Commun 9:1305","journal-title":"Nat Commun"},{"key":"2613_CR116","unstructured":"Fatima Jinnah Medical University (2023) PRP and PBD-VSEL stem cell therapy for Parkinson\u2019s disease (ClinicalTrials.gov) Available at: https:\/\/clinicaltrials.gov\/study\/NCT06142981?cond=Parkinson%20Disease&intr=stem%20cells&start=2019-01-01_&aggFilters=status:com&rank=4 .Accessed 12 Aug. 2024."},{"key":"2613_CR117","unstructured":"Schiess, M. (2024). Phase IIa randomized placebo controlled trial: mesenchymal stem cells as a disease-modifying therapy for idiopathic Parkinson\u2019s disease (ClinicalTrials.gov) available at: https:\/\/clinicaltrials.gov\/study\/NCT04506073?cond=Parkinson%20Disease&intr=stem%20cells&start=2019-01-01_&aggFilters=status:com&rank=1 .Accessed 12 Aug. 2024."},{"key":"2613_CR118","unstructured":"Shanghai East Hospital (2023) Stereotactic transplantation of hAESCs for Parkinson\u2019s disease (ClinicalTrials.gov) available at: https:\/\/clinicaltrials.gov\/study\/NCT04414813?cond=Parkinson%20Disease&intr=stem%20cells&start=2019-01-01_&aggFilters=status:com&rank=2. Accessed 12 Aug 2024"},{"key":"#cr-split#-2613_CR119.1","unstructured":"Hope Biosciences Stem Cell Research Foundation (2024) Randomized, double-blind clinical trial for Parkinson's disease (early and moderate)"},{"key":"#cr-split#-2613_CR119.2","unstructured":"(PD) (ClinicalTrials.gov) Available at:https:\/\/clinicaltrials.gov\/study\/NCT04928287?cond=Parkinson%20Disease&intr=stem%20cells&start=2019-01-01_&aggFilters=status:com&rank=3. Accessed 12 Aug 2024"},{"key":"2613_CR120","unstructured":"iRegene Therapeutics Co., Ltd. (2024). The safety, tolerability and efficacy of NouvNeu001 for Parkinson\u2019s disease (ClinicalTrials.gov) Available at: https:\/\/clinicaltrials.gov\/study\/NCT06167681?cond=Parkinson%20Disease&intr=stem%20cells&start=2019-01-01_&aggFilters=status:rec&rank=1 .Accessed 2 Aug. 2024."},{"key":"2613_CR121","unstructured":"Region Skane (2024) A trial to determine the safety and tolerability of transplanted stem cell derived dopamine neurons to the brains of individuals with Parkinson\u2019s disease (STEM-PD) (ClinicalTrials.gov) Available at: https:\/\/clinicaltrials.gov\/study\/NCT05635409?cond=Parkinson%20Disease&intr=stem%20cells&start=2019-01-01_&aggFilters=status:rec&rank=2. Accessed 12 Aug 2024"},{"key":"2613_CR122","unstructured":"Wu J (2023) Precise transplantation of human amniotic epithelial stem cells into lateral ventricle for Parkinson\u2019s disease (ClinicalTrials.gov) Available at: https:\/\/clinicaltrials.gov\/study\/NCT05691114?cond=Parkinson%20Disease&intr=stem%20cells&start=2019-01-01_&aggFilters=status:rec&rank=3. Accessed 12 Aug 2024"},{"key":"2613_CR123","unstructured":"Xuanwu Hospital, Beijing (2023) Safety and efficacy of autologous iNSC-DAP in the treatment of Parkinson\u2019s disease (ClinicalTrials.gov) Available at: https:\/\/clinicaltrials.gov\/study\/NCT05901818?cond=Parkinson%20Disease&intr=stem%20cells&start=2019-01-01_&aggFilters=status:rec&rank=4. Accessed 12 Aug 2024"},{"key":"2613_CR124","unstructured":"Ciacci J (2024). Transplantation of human iPS cell-derived dopaminergic progenitors (CT1-DAP001) for Parkinson\u2019s disease (Phase I\/II) (CT1-DAP001) (ClinicalTrials.gov) Available at: https:\/\/clinicaltrials.gov\/study\/NCT06482268?cond=Parkinson%20Disease&intr=stem%20cells&start=2019-01-01_&aggFilters=status:rec&rank=5. Accessed 12 Aug. 2024"},{"key":"2613_CR125","unstructured":"Hope Biosciences Stem Cell Research Foundation (2024) Clinical trial for Parkinson\u2019s disease using allogeneic HB-adMSCs (early and moderate PD) (ClinicalTrials.gov) Available at: https:\/\/clinicaltrials.gov\/study\/NCT04995081?cond=Parkinson%20Disease&intr=stem%20cells&start=2019-01-01_&aggFilters=status:rec&rank=7. Accessed 12 Aug 2024"},{"key":"2613_CR126","unstructured":"Sociedad Espa\u00f1ola de Medicina Regenerativa y Terapia Celular (2024). Clinical study on the efficacy of natural stem cell mobilizers on parkinson disease (ClinicalTrials.gov) available at: https:\/\/clinicaltrials.gov\/study\/NCT05699694?cond=Parkinson%20Disease&intr=stem%20cells&start=2019-01-01_&aggFilters=status:rec&rank=6 .Accessed 12 Aug. 2024]."},{"key":"2613_CR127","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/mds.29316","volume":"38","author":"J Kim","year":"2023","unstructured":"Kim J, Inbo H, Kim HS, Kim W, Jang SJ, Min K, Kim SH, Bae S-H, Jeong Y-H, Kim B et al (2023) First clinical report on the treatment of Parkinson\u2019s disease with fetal midbrain precursor cells. Mov Disord 38:589\u2013603","journal-title":"Mov Disord"},{"key":"2613_CR128","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/ane.13547","volume":"145","author":"K Shigematsu","year":"2022","unstructured":"Shigematsu K, Komori N, Tahara K, Yamagishi H (2022) Repeated infusion of autologous adipose tissue-derived stem cells for Parkinson\u2019s disease. Acta Neurol Scand 145:119\u2013122","journal-title":"Acta Neurol Scand"},{"key":"2613_CR129","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","volume":"382","author":"JS Schweitzer","year":"2020","unstructured":"Schweitzer JS, Song B, Herrington TM, Park T-Y, Lee N, Ko S, Jeon J, Cha Y, Kim K, Li Q et al (2020) Personalized iPSC-derived dopamine progenitor cells for Parkinson\u2019s disease. N Engl J Med 382:1926\u20131932","journal-title":"N Engl J Med"},{"key":"2613_CR130","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1007\/s11033-020-05353-2","volume":"47","author":"CR Balistreri","year":"2020","unstructured":"Balistreri CR, De Falco E, Bordin A, Maslova O, Koliada A, Vaiserman A (2020) Stem cell therapy: old challenges and new solutions. Mol Biol Rep 47:3117\u20133131","journal-title":"Mol Biol Rep"},{"key":"2613_CR131","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s40291-023-00662-1","volume":"27","author":"Y-A Heo","year":"2023","unstructured":"Heo Y-A (2023) Omidubicel: first approval. Mol Diagn Ther 27:637\u2013642","journal-title":"Mol Diagn Ther"},{"key":"2613_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1202027","volume":"17","author":"R Nakamura","year":"2023","unstructured":"Nakamura R, Nonaka R, Oyama G, Jo T, Kamo H, Nuermaimaiti M, Akamatsu W, Ishikawa K-I, Hattori N (2023) A defined method for differentiating human iPSCs into midbrain dopaminergic progenitors that safely restore motor deficits in Parkinson\u2019s disease. Front Neurosci 17:1202027","journal-title":"Front Neurosci"},{"key":"2613_CR133","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.biomaterials.2015.09.039","volume":"74","author":"T-Y Wang","year":"2016","unstructured":"Wang T-Y, Bruggeman KF, Kauhausen JA, Rodriguez AL, Nisbet DR, Parish CL (2016) Functionalized composite scaffolds improve the engraftment of transplanted dopaminergic progenitors in a mouse model of Parkinson\u2019s disease. Biomaterials 74:89\u201398","journal-title":"Biomaterials"},{"key":"2613_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052850","author":"M Mousaei Ghasroldasht","year":"2022","unstructured":"Mousaei Ghasroldasht M, Seok J, Park H-S, Liakath Ali FB, Al-Hendy A (2022) Stem cell therapy: from idea to clinical practice. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23052850","journal-title":"Int J Mol Sci"},{"key":"2613_CR135","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/j.1474-9726.2007.00336.x","volume":"6","author":"C Fehrer","year":"2007","unstructured":"Fehrer C, Brunauer R, Laschober G, Unterluggauer H, Reitinger S, Kloss F, G\u00fclly C, Gassner R, Lepperdinger G (2007) Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 6:745\u2013757","journal-title":"Aging Cell"},{"key":"2613_CR136","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s12015-023-10658-3","volume":"20","author":"N Jiang","year":"2024","unstructured":"Jiang N, Tian X, Wang Q, Hao J, Jiang J, Wang H (2024) Regulation mechanisms and maintenance strategies of stemness in mesenchymal stem cells. Stem Cell Rev and Rep 20:455\u2013483","journal-title":"Stem Cell Rev and Rep"},{"key":"2613_CR137","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s13287-019-1404-9","volume":"10","author":"N Liao","year":"2019","unstructured":"Liao N, Shi Y, Zhang C, Zheng Y, Wang Y, Zhao B, Zeng Y, Liu X, Liu J (2019) Antioxidants inhibit cell senescence and preserve stemness of adipose tissue-derived stem cells by reducing ROS generation during long-term in vitro expansion. Stem Cell Res Ther 10:306","journal-title":"Stem Cell Res Ther"},{"key":"2613_CR138","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13287-018-0825-1","volume":"9","author":"K Fujisawa","year":"2018","unstructured":"Fujisawa K, Hara K, Takami T, Okada S, Matsumoto T, Yamamoto N, Sakaida I (2018) Evaluation of the effects of ascorbic acid on metabolism of human mesenchymal stem cells. Stem Cell Res Ther 9:93","journal-title":"Stem Cell Res Ther"},{"key":"2613_CR139","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13770-021-00406-4","volume":"19","author":"HJ Kim","year":"2022","unstructured":"Kim HJ, Kim G, Lee J, Lee Y, Kim J-H (2022) Secretome of stem cells: roles of extracellular vesicles in diseases, stemness, differentiation, and reprogramming. Tissue Eng Regen Med 19:19\u201333","journal-title":"Tissue Eng Regen Med"},{"key":"2613_CR140","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.devcel.2020.11.017","volume":"56","author":"YH Hur","year":"2021","unstructured":"Hur YH, Feng S, Wilson KF, Cerione RA, Antonyak MA (2021) Embryonic stem cell-derived extracellular vesicles maintain ESC stemness by activating FAK. Dev Cell 56:277-291.e6","journal-title":"Dev Cell"},{"key":"2613_CR141","doi-asserted-by":"publisher","first-page":"8904","DOI":"10.1038\/s41598-022-12653-z","volume":"12","author":"HA Hamid","year":"2022","unstructured":"Hamid HA, Ramasamy R, Mustafa MK, Hosseinpour Sarmadi V, Miskon A (2022) Magnetic exposure using samarium cobalt (SmCO5) increased proliferation and stemness of human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs). Sci Rep 12:8904","journal-title":"Sci Rep"},{"key":"2613_CR142","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.scr.2018.09.006","volume":"32","author":"F Bianchi","year":"2018","unstructured":"Bianchi F, Malboubi M, Li Y, George JH, Jerusalem A, Szele F, Thompson MS, Ye H (2018) Rapid and efficient differentiation of functional motor neurons from human iPSC for neural injury modelling. Stem Cell Res 32:126\u2013134","journal-title":"Stem Cell Res"},{"key":"2613_CR143","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-1-0716-1979-7_10","volume":"2429","author":"MC Silva","year":"2022","unstructured":"Silva MC, Nandi G, Haggarty SJ (2022) Differentiation of human induced pluripotent stem cells into cortical neurons to advance precision medicine. Methods Mol Biol 2429:143\u2013174","journal-title":"Methods Mol Biol"},{"key":"2613_CR144","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/978-1-4939-9631-5_21","volume":"2029","author":"RA Shparberg","year":"2019","unstructured":"Shparberg RA, Glover HJ, Morris MB (2019) Embryoid body differentiation of mouse embryonic stem cells into neurectoderm and neural progenitors. Methods Mol Biol 2029:273\u2013285","journal-title":"Methods Mol Biol"},{"key":"2613_CR145","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/lsm.23265","volume":"52","author":"S George","year":"2020","unstructured":"George S, Hamblin MR, Abrahamse H (2020) Photobiomodulation-induced differentiation of immortalized adipose stem cells to neuronal cells. Lasers Surg Med 52:1032\u20131040","journal-title":"Lasers Surg Med"},{"key":"2613_CR146","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.ultrasmedbio.2014.05.001","volume":"40","author":"I-C Lee","year":"2014","unstructured":"Lee I-C, Lo T-L, Young T-H, Li Y-C, Chen NG, Chen C-H, Chang Y-C (2014) Differentiation of neural stem\/progenitor cells using low-intensity ultrasound. Ultrasound Med Biol 40:2195\u20132206","journal-title":"Ultrasound Med Biol"},{"key":"2613_CR147","doi-asserted-by":"publisher","first-page":"15869","DOI":"10.1038\/s41598-022-19018-6","volume":"12","author":"EL Cantor","year":"2022","unstructured":"Cantor EL, Shen F, Jiang G, Tan Z, Cunningham GM, Wu X, Philips S, Schneider BP (2022) Passage number affects differentiation of sensory neurons from human induced pluripotent stem cells. Sci Rep 12:15869","journal-title":"Sci Rep"},{"key":"2613_CR148","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s40001-024-01987-1","volume":"29","author":"R Rahimi Darehbagh","year":"2024","unstructured":"Rahimi Darehbagh R, Seyedoshohadaei SA, Ramezani R, Rezaei N (2024) Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives. Eur J Med Res 29:386","journal-title":"Eur J Med Res"},{"key":"2613_CR149","doi-asserted-by":"crossref","unstructured":"Hachimi-Idrissi S (2023) Stem cell therapy in neurological disorders: promises and concerns. Explor Neuroprotective Ther 346\u2013362","DOI":"10.37349\/ent.2023.00055"},{"key":"2613_CR150","doi-asserted-by":"publisher","unstructured":"Jamali FA, Dahbour SS (2017) Stem cell therapies in neurological disorders. In: El-Badri N (ed) Advances in stem cell therapy. Stem Cell Biology and Regenerative Medicine. Humana Press, Cham. ISBN: 978-3-319-29147-5. https:\/\/doi.org\/10.1007\/978-3-319-29149-9_3","DOI":"10.1007\/978-3-319-29149-9_3"},{"key":"2613_CR151","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/jnr.22054","volume":"87","author":"SU Kim","year":"2009","unstructured":"Kim SU, de Vellis J (2009) Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res 87:2183\u20132200","journal-title":"J Neurosci Res"},{"key":"2613_CR152","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13287-019-1165-5","volume":"10","author":"W Zakrzewski","year":"2019","unstructured":"Zakrzewski W, Dobrzy\u0144ski M, Szymonowicz M, Rybak Z (2019) Stem cells: past, present, and future. Stem Cell Res Ther 10:68","journal-title":"Stem Cell Res Ther"},{"key":"2613_CR153","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/MIB.0b013e31827f27df","volume":"19","author":"L Mayer","year":"2013","unstructured":"Mayer L, Pandak WM, Melmed GY, Hanauer SB, Johnson K, Payne D, Faleck H, Hariri RJ, Fischkoff SA (2013) Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn\u2019s disease: a phase 1 study. Inflamm Bowel Dis 19:754\u2013760","journal-title":"Inflamm Bowel Dis"},{"key":"2613_CR154","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.msard.2014.08.002","volume":"3","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Bowen JD, Huddlestone J, Kremenchutzky M, Carpenter A, Corboy JR, Freedman MS, Krupp L, Paulo C, Hariri RJ et al (2014) Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study. Multiple Sclerosis and Related Disorders 3:696\u2013704","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"2613_CR155","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.stem.2009.11.009","volume":"5","author":"K Saha","year":"2009","unstructured":"Saha K, Jaenisch R (2009) Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 5:584\u2013595","journal-title":"Cell Stem Cell"},{"issue":"Suppl","key":"2613_CR156","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng1089","volume":"33","author":"R Jaenisch","year":"2003","unstructured":"Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl):245\u2013254","journal-title":"Nat Genet"},{"key":"2613_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2018.04.005","volume":"168","author":"K-C Sonntag","year":"2018","unstructured":"Sonntag K-C, Song B, Lee N, Jung JH, Cha Y, Leblanc P, Neff C, Kong SW, Carter BS, Schweitzer J et al (2018) Pluripotent stem cell-based therapy for Parkinson\u2019s disease: current status and future prospects. Prog Neurobiol 168:1\u201320","journal-title":"Prog Neurobiol"},{"key":"2613_CR158","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4103\/1673-5374.202935","volume":"12","author":"TB Stoker","year":"2017","unstructured":"Stoker TB, Blair NF, Barker RA (2017) Neural grafting for Parkinson\u2019s disease: challenges and prospects. Neural Regen Res 12:389\u2013392","journal-title":"Neural Regen Res"},{"key":"2613_CR159","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1002\/cne.23577","volume":"522","author":"PC Buttery","year":"2014","unstructured":"Buttery PC, Barker RA (2014) Treating Parkinson\u2019s disease in the 21st century: can stem cell transplantation compete? J Comp Neurol 522:2802\u20132816","journal-title":"J Comp Neurol"},{"key":"2613_CR160","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1073\/pnas.1605245113","volume":"113","author":"W Li","year":"2016","unstructured":"Li W, Englund E, Widner H, Mattsson B, van Westen D, L\u00e4tt J, Rehncrona S, Brundin P, Bj\u00f6rklund A, Lindvall O et al (2016) Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain. Proc Natl Acad Sci U S A 113:6544\u20136549","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2613_CR161","doi-asserted-by":"publisher","first-page":"576","DOI":"10.5966\/sctm.2015-0228","volume":"6","author":"J Moon","year":"2017","unstructured":"Moon J, Schwarz SC, Lee H-S, Kang JM, Lee Y-E, Kim B, Sung M-Y, H\u00f6glinger G, Wegner F, Kim JS et al (2017) Preclinical analysis of fetal human mesencephalic neural progenitor cell lines: characterization and safety in vitro and in vivo. Stem Cells Transl Med 6:576\u2013588","journal-title":"Stem Cells Transl Med"},{"key":"2613_CR162","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12910-023-00966-1","volume":"24","author":"KS Bywall","year":"2023","unstructured":"Bywall KS, Drevin J, Groothuis-Oudshoorn C, Veldwijk J, Nyholm D, Widner H, van Vliet T, Jiltsova E, Hansson M, Johansson JV (2023) Patients accept therapy using embryonic stem cells for Parkinson\u2019s disease: a discrete choice experiment. BMC Med Ethics 24:83","journal-title":"BMC Med Ethics"},{"key":"2613_CR163","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12910-022-00829-1","volume":"23","author":"G Samuel","year":"2022","unstructured":"Samuel G, Hardcastle F, Broekstra R, Lucassen A (2022) Exploring how biobanks communicate the possibility of commercial access and its associated benefits and risks in participant documents. BMC Med Ethics 23:95","journal-title":"BMC Med Ethics"},{"key":"2613_CR164","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00253","volume":"6","author":"M Prictor","year":"2018","unstructured":"Prictor M, Teare HJA, Kaye J (2018) Equitable participation in biobanks: the risks and benefits of a \u201cdynamic consent\u201d approach. Front Public Health 6:253","journal-title":"Front Public Health"},{"key":"2613_CR165","doi-asserted-by":"publisher","unstructured":"Khurana V, Kwatra D, Shah S, Mandal A, Mitra AK (2017) Emerging nanotechnology for stem cell therapy. In: Mitra AK, Cholkar K, Mandal A (eds) Emerging nanotechnologies for diagnostics, drug delivery and medical devices. Micro and Nano Technologies. Elsevier, pp 85\u2013103. ISBN: 9780323429788.https:\/\/doi.org\/10.1016\/B978-0-323-42978-8.00005-X","DOI":"10.1016\/B978-0-323-42978-8.00005-X"},{"key":"2613_CR166","doi-asserted-by":"publisher","first-page":"111236","DOI":"10.1016\/j.biopha.2021.111236","volume":"137","author":"Y Dong","year":"2021","unstructured":"Dong Y, Wu X, Chen X, Zhou P, Xu F, Liang W (2021) Nanotechnology shaping stem cell therapy: recent advances, application, challenges, and future outlook. Biomed Pharmacother 137:111236","journal-title":"Biomed Pharmacother"},{"key":"2613_CR167","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1007\/s12035-015-9199-x","volume":"53","author":"Z Bagher","year":"2016","unstructured":"Bagher Z, Azami M, Ebrahimi-Barough S, Mirzadeh H, Solouk A, Soleimani M, Ai J, Nourani MR, Joghataei MT (2016) Differentiation of Wharton\u2019s jelly-derived mesenchymal stem cells into motor neuron-like cells on three-dimensional collagen-grafted nanofibers. Mol Neurobiol 53:2397\u20132408","journal-title":"Mol Neurobiol"},{"key":"2613_CR168","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/jbm.a.36062","volume":"105","author":"G Lalwani","year":"2017","unstructured":"Lalwani G, D\u2019agati M, Gopalan A, Patel SC, Talukdar Y, Sitharaman B (2017) Three-dimensional carbon nanotube scaffolds for long-term maintenance and expansion of human mesenchymal stem cells. J Biomed Mater Res A 105:1927\u20131939","journal-title":"J Biomed Mater Res A"},{"key":"2613_CR169","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s13534-024-00374-3","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Chen S, Huang C, Dai Y, Zhu S, Wang R, Gou X (2024) Dynamic regulation of stem cell adhesion and differentiation on degradable piezoelectric poly (L-lactic acid) (PLLA) nanofibers. Biomed Eng Lett 14:775\u2013784","journal-title":"Biomed Eng Lett"},{"key":"2613_CR170","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.carbon.2017.02.049","volume":"116","author":"X Zhou","year":"2017","unstructured":"Zhou X, Nowicki M, Cui H, Zhu W, Fang X, Miao S, Lee S-J, Keidar M, Zhang LG (2017) 3D bioprinted graphene oxide-incorporated matrix for promoting chondrogenic differentiation of human bone marrow mesenchymal stem cells. Carbon 116:615\u2013624","journal-title":"Carbon"},{"key":"2613_CR171","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04344-9","author":"A Bostani","year":"2024","unstructured":"Bostani A, Hoveizi E, Naddaf H, Razeghi J (2024) Nerve regeneration through differentiation of endometrial-derived mesenchymal stem cells into nerve-like cells using polyacrylonitrile\/chitosan conduit and berberine in a rat sciatic nerve injury model. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-04344-9","journal-title":"Mol Neurobiol"},{"key":"2613_CR172","doi-asserted-by":"publisher","first-page":"7663","DOI":"10.1039\/D3BM00801K","volume":"11","author":"J Hu","year":"2023","unstructured":"Hu J, Li C, Yang Z, Wu Q, Wang J, Xu Z, Chen Y, Wan Q, Shuai Y, Yang S et al (2023) Hierarchically patterned protein scaffolds with nano-fibrillar and micro-lamellar structures modulate neural stem cell homing and promote neuronal differentiation. Biomater Sci 11:7663\u20137677","journal-title":"Biomater Sci"},{"key":"2613_CR173","doi-asserted-by":"publisher","first-page":"37497","DOI":"10.1021\/acsami.4c05004","volume":"16","author":"J Li","year":"2024","unstructured":"Li J, Li X, Li X, Liang Z, Wang Z, Shahzad KA, Xu M, Tan F (2024) Local delivery of dual stem cell-derived exosomes using an electrospun nanofibrous platform for the treatment of traumatic brain injury. ACS Appl Mater Interfaces 16:37497\u201337512","journal-title":"ACS Appl Mater Interfaces"},{"key":"2613_CR174","doi-asserted-by":"publisher","first-page":"101109","DOI":"10.1016\/j.mtbio.2024.101109","volume":"26","author":"Y Tai","year":"2024","unstructured":"Tai Y, Goodrich R, Maldonado M, Ortiz J, Martinez J, Ico G, Ko A, Shih HP, Nam J (2024) Nanofiber-microwell cell culture system for spatially patterned differentiation of pluripotent stem cells in 3D. Mater Today Bio 26:101109","journal-title":"Mater Today Bio"},{"key":"2613_CR175","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12062395","author":"R Jalli","year":"2023","unstructured":"Jalli R, Mehrabani D, Zare S, Saeedi Moghadam M, Jamhiri I, Manafi N, Mehrabani G, Ghabanchi J, Razeghian Jahromi I, Rasouli-Nia A et al (2023) Cell proliferation, viability, differentiation, and apoptosis of iron oxide labeled stem cells transfected with lipofectamine assessed by MRI. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12062395","journal-title":"J Clin Med"},{"key":"2613_CR176","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1038\/s41598-023-51076-2","volume":"14","author":"Q Gao","year":"2024","unstructured":"Gao Q, Chen J, Zuo W, Wang B, Song T, Xu C, Yu W, Dai Y, Gao S, Zhu L et al (2024) ADSCs labeled with SPIONs tracked in corpus cavernosum of rat and miniature pig by MR imaging and histological examination. Sci Rep 14:1917","journal-title":"Sci Rep"},{"key":"2613_CR177","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-1-0716-3995-5_8","volume":"2835","author":"J Wolnik","year":"2024","unstructured":"Wolnik J, Adamska P, Oleksy A, Dulak J, Biniecka M (2024) Enriching cardiomyocytes derived from hiPSCs by magnetic-activated cell sorting (MACS). Methods Mol Biol 2835:83\u201398","journal-title":"Methods Mol Biol"},{"key":"2613_CR178","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.1021\/acs.biomac.2c00853","volume":"23","author":"PV Torres-Ortega","year":"2022","unstructured":"Torres-Ortega PV, Del Campo-Montoya R, Plano D, Paredes J, Aldazabal J, Luquin M-R, Santamar\u00eda E, Sanmart\u00edn C, Blanco-Prieto MJ, Garbayo E (2022) Encapsulation of mscs and GDNF in an injectable nanoreinforced supramolecular hydrogel for brain tissue engineering. Biomacromol 23:4629\u20134644","journal-title":"Biomacromol"},{"key":"2613_CR179","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12951-024-02587-1","volume":"22","author":"T Lei","year":"2024","unstructured":"Lei T, Li C, Liu Y, Cui Z, Deng S, Cao J, Yang H, Chen P (2024) Microfluidics-enabled mesenchymal stem cell derived neuron like cell membrane coated nanoparticles inhibit inflammation and apoptosis for Parkinson\u2019s Disease. J Nanobiotechnology 22:370","journal-title":"J Nanobiotechnology"},{"key":"2613_CR180","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.actbio.2024.05.020","volume":"183","author":"TG Mathes","year":"2024","unstructured":"Mathes TG, Monirizad M, Ermis M, de Barros NR, Rodriguez M, Kraatz H-B, Jucaud V, Khademhosseini A, Falcone N (2024) Effects of amyloid-\u03b2-mimicking peptide hydrogel matrix on neuronal progenitor cell phenotype. Acta Biomater 183:89\u2013100","journal-title":"Acta Biomater"},{"key":"2613_CR181","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.3390\/cimb45060290","volume":"45","author":"LSA Valerio","year":"2023","unstructured":"Valerio LSA, Carrick FR, Bedoya L, Sreerama S, Sugaya K (2023) Neural differentiation of induced pluripotent stem cells for a xenogeneic material-free 3D neurological disease model neurulation from pluripotent cells using a human hydrogel. Curr Issues Mol Biol 45:4574\u20134588","journal-title":"Curr Issues Mol Biol"},{"key":"2613_CR182","doi-asserted-by":"publisher","DOI":"10.1088\/1741-2552\/ad33b2","author":"G Comini","year":"2024","unstructured":"Comini G, Kelly R, Jarrin S, Patton T, Narasimhan K, Pandit A, Drummond N, Kunath T, Dowd E (2024) Survival and maturation of human induced pluripotent stem cell-derived dopaminergic progenitors in the parkinsonian rat brain is enhanced by transplantation in a neurotrophin-enriched hydrogel. J Neural Eng. https:\/\/doi.org\/10.1088\/1741-2552\/ad33b2","journal-title":"J Neural Eng"},{"key":"2613_CR183","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/bem.22046","volume":"38","author":"AR Aikins","year":"2017","unstructured":"Aikins AR, Hong S-W, Kim H-J, Yoon C-H, Chung J-H, Kim M, Kim C-W (2017) Extremely low-frequency electromagnetic field induces neural differentiation of hBM-MSCs through regulation of (Zn)-metallothionein-3. Bioelectromagnetics 38:364\u2013373","journal-title":"Bioelectromagnetics"},{"key":"2613_CR184","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/btpr.1607","volume":"28","author":"H Cho","year":"2012","unstructured":"Cho H, Seo Y-K, Yoon H-H, Kim S-C, Kim S-M, Song K-Y, Park J-K (2012) Neural stimulation on human bone marrow-derived mesenchymal stem cells by extremely low frequency electromagnetic fields. Biotechnol Prog 28:1329\u20131335","journal-title":"Biotechnol Prog"},{"key":"2613_CR185","doi-asserted-by":"publisher","first-page":"136765","DOI":"10.1016\/j.neulet.2022.136765","volume":"784","author":"T Jadidi","year":"2022","unstructured":"Jadidi T, Asadian N, Jadidi M, Ali Vafaei A (2022) EMF promote BMSCs differentiation and functional recovery in hemiparkinsonian rats. Neurosci Lett 784:136765","journal-title":"Neurosci Lett"},{"key":"2613_CR186","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25074038","author":"J Isakovi\u0107","year":"2024","unstructured":"Isakovi\u0107 J, Slatkovi\u0107 F, Jage\u010di\u0107 D, Petrovi\u0107 DJ, Mitre\u010di\u0107 D (2024) Pulsating extremely low-frequency electromagnetic fields influence differentiation of mouse neural stem cells towards astrocyte-like phenotypes: in vitro pilot study. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25074038","journal-title":"Int J Mol Sci"},{"key":"2613_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121157","volume":"278","author":"Y Chang","year":"2021","unstructured":"Chang Y, Cho B, Lee E, Kim J, Yoo J, Sung J-S, Kwon Y, Kim J (2021) Electromagnetized gold nanoparticles improve neurogenesis and cognition in the aged brain. Biomaterials 278:121157","journal-title":"Biomaterials"},{"key":"2613_CR188","doi-asserted-by":"publisher","first-page":"2181942","DOI":"10.1155\/2017\/2181942","volume":"2017","author":"N Cicho\u0144","year":"2017","unstructured":"Cicho\u0144 N, Czarny P, Bijak M, Miller E, \u015aliwi\u0144ski T, Szemraj J, Saluk-Bijak J (2017) Benign effect of extremely low-frequency electromagnetic field on brain plasticity assessed by nitric oxide metabolism during poststroke rehabilitation. Oxid Med Cell Longev 2017:2181942","journal-title":"Oxid Med Cell Longev"},{"key":"2613_CR189","doi-asserted-by":"publisher","first-page":"135463","DOI":"10.1016\/j.neulet.2020.135463","volume":"741","author":"W Bai","year":"2021","unstructured":"Bai W, Li M, Xu W, Zhang M (2021) Comparison of effects of high- and low-frequency electromagnetic fields on proliferation and differentiation of neural stem cells. Neurosci Lett 741:135463","journal-title":"Neurosci Lett"},{"key":"2613_CR190","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1007\/s12035-014-8650-8","volume":"49","author":"L Leone","year":"2014","unstructured":"Leone L, Fusco S, Mastrodonato A, Piacentini R, Barbati SA, Zaffina S, Pani G, Podda MV, Grassi C (2014) Epigenetic modulation of adult hippocampal neurogenesis by extremely low-frequency electromagnetic fields. Mol Neurobiol 49:1472\u20131486","journal-title":"Mol Neurobiol"},{"key":"2613_CR191","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/nnano.2017.133","volume":"12","author":"J Yoo","year":"2017","unstructured":"Yoo J, Lee E, Kim HY, Youn D-H, Jung J, Kim H, Chang Y, Lee W, Shin J, Baek S et al (2017) Electromagnetized gold nanoparticles mediate direct lineage reprogramming into induced dopamine neurons in vivo for Parkinson\u2019s disease therapy. Nat Nanotechnol 12:1006\u20131014","journal-title":"Nat Nanotechnol"},{"key":"2613_CR192","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.expneurol.2014.09.014","volume":"263","author":"J Liu","year":"2015","unstructured":"Liu J, Zhu B, Zhang G, Wang J, Tian W, Ju G, Wei X, Song B (2015) Electric signals regulate directional migration of ventral midbrain derived dopaminergic neural progenitor cells via Wnt\/GSK3\u03b2 signaling. Exp Neurol 263:113\u2013121","journal-title":"Exp Neurol"},{"key":"2613_CR193","doi-asserted-by":"publisher","first-page":"20220576","DOI":"10.1098\/rsif.2022.0576","volume":"19","author":"K Dhillon","year":"2022","unstructured":"Dhillon K, Aizel K, Broomhall TJ, Secret E, Goodman T, Rotherham M, Telling N, Siaugue JM, M\u00e9nager C, Fresnais J et al (2022) Directional control of neurite outgrowth: emerging technologies for Parkinson\u2019s disease using magnetic nanoparticles and magnetic field gradients. J R Soc Interface 19:20220576","journal-title":"J R Soc Interface"},{"key":"2613_CR194","doi-asserted-by":"publisher","unstructured":"Sch\u00f6neborn H, Raudzus F, Secret E, Otten N, Michel A, Fresnais J, M\u00e9nager C, Siaugue J-M, Zaehres H, Dietzel ID et al (2019) Novel tools towards magnetic guidance of neurite growth: (I) guidance of magnetic nanoparticles into neurite extensions of induced human neurons and in vitro functionalization with RAS regulating proteins. J Funct Biomater 10. https:\/\/doi.org\/10.3390\/jfb10030032","DOI":"10.3390\/jfb10030032"},{"key":"2613_CR195","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.nano.2013.12.008","volume":"10","author":"C Riggio","year":"2014","unstructured":"Riggio C, Calatayud MP, Giannaccini M, Sanz B, Torres TE, Fern\u00e1ndez-Pacheco R, Ripoli A, Ibarra MR, Dente L, Cuschieri A et al (2014) The orientation of the neuronal growth process can be directed via magnetic nanoparticles under an applied magnetic field. Nanomedicine 10:1549\u20131558","journal-title":"Nanomedicine"},{"key":"2613_CR196","doi-asserted-by":"publisher","first-page":"22452","DOI":"10.1038\/s41598-020-80253-w","volume":"10","author":"F Raudzus","year":"2020","unstructured":"Raudzus F, Sch\u00f6neborn H, Neumann S, Secret E, Michel A, Fresnais J, Brylski O, M\u00e9nager C, Siaugue J-M, Heumann R (2020) Magnetic spatiotemporal control of SOS1 coupled nanoparticles for guided neurite growth in dopaminergic single cells. Sci Rep 10:22452","journal-title":"Sci Rep"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02613-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-025-02613-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02613-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T13:01:42Z","timestamp":1765630902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-025-02613-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":197,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2613"],"URL":"https:\/\/doi.org\/10.1007\/s00109-025-02613-1","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"19 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}